UNSPSC 51292705: Cilobamine mesilate or mesylate

This classification denotes an antidepressant agent with the molecular formula C17H23Cl2NO.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SZ83PVQ06I, chemically known as bicyclo(2.2.2)octan-2-ol, 2-(3,4-dichlorophenyl)-3-((1-methylethyl)amino)-, cis-, methanesulfonate (salt), but more generally known as cilobamine mesylate, which bears US NIH Compound Identifier 50537. European Medicines Agency schedules cilobamine mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06269MIG.

UNSPSC 51292705 Cilobamine mesilate or mesylate is a Commodity code that does not align with state and local procurement activity in the available recent-opportunities record. The three most recent opportunities posted under or near this code—naloxone and drug deactivation systems for Seminole County, Florida; a direct-to-manufacturer prescription program inquiry from the Texas Health and Human Services Commission; and a multistate generic pharmaceutical and OTC product contract from the Minnesota Multistate Cooperative Purchasing Alliance—address naloxone, prescription fulfillment logistics, and broad-spectrum generic pharmaceuticals and over-the-counter products, respectively. None of these solicitations specifically procure or reference cilobamine mesilate or mesylate as a line item, active ingredient focus, or procurement target. The code's nominal scope (a specific pharmaceutical chemical compound) diverges substantially from the scope of work actually being solicited under the tagged opportunities.

The recent activity reflects pharmaceutical and health-system procurement by state health agencies and county health departments, but the opportunities are organized around product categories (naloxone, generic pharmaceuticals), therapeutic programs (direct-to-manufacturer arrangements), and delivery channels (wholesaler-mediated distribution) rather than individual chemical entities. No recent state or local contract opportunities show demonstrated market demand for cilobamine mesilate or mesylate as a standalone procurement category. Professionals evaluating whether to pursue this code should verify whether state and local purchasing offices actually use this commodity code for active solicitations or whether the tagging reflects a classification mismatch in the source system.